Welcome to our dedicated page for PureCycle Technologies SEC filings (Ticker: PCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
PureCycle Technologies filings document its recycled polypropylene business, governance, and capital structure. Recent 8-K reports disclose operating results, investor presentations, Ironton production updates, PureFive resin commercialization activity, and material agreements affecting the company’s outstanding warrants.
Proxy and shareholder-vote filings cover director elections, auditor ratification, executive compensation votes, and consent solicitations for warrant holders. The filing record also describes common stock, public and private warrants, Series A warrants, warrant agreement amendments, redemption mechanics, expiration terms, and other capital-structure matters tied to the company’s securities.
PureCycle Technologies, Inc. obtained majority warrant holder consent to amend the terms of its public and private warrants. The company reduced the warrant redemption trigger price from $18.00 per share to $14.38 per share and extended the warrant expiration to 5:00 p.m. New York City time on the earlier of March 17, 2027, or any redemption date. Holders delivered written consents totaling 3,997,627 “for,” 7,433 “against,” and 144,402 abstentions. These warrant amendments become effective as of June 17, 2026.
PureCycle Technologies, Inc. Chief Financial Officer Donald Carpenter filed an initial Form 3 showing his existing equity stake in the company. He directly holds 135,539 shares of Common Stock, plus four blocks of employee stock options covering 10,793, 10,718, 8,887, and 23,426 underlying common shares. These options have exercise prices of $5.72, $5.73, $10.58, and $8.58 per share and expire between 2033 and 2036. A footnote states that exercise of the nonqualified award is subject to vesting three years after the grant date, highlighting that some option value depends on continued service.
PureCycle Technologies Inc filed an Amendment No. 3 to Schedule 13G/A reporting that The Vanguard Group holds 0 shares and 0% of the class following an internal realignment. The filing states Vanguard's subsidiaries will report beneficial ownership separately in reliance on January 12, 1998, and that the realignment occurred on January 12, 2026. The form is signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026.
PureCycle Technologies has called its 2026 annual shareholder meeting for May 7, 2026, at 10:00 a.m. ET as a virtual-only event, with March 17, 2026 as the record date for 180,725,284 outstanding common shares.
Shareholders will vote on three items: electing nine directors (including newer appointees Dr. Siri Jirapongphan and Valerie Mars) to one-year terms, ratifying Grant Thornton LLP as auditor for fiscal 2026, and an advisory “say‑on‑pay” resolution on named executive officer compensation.
The proxy highlights 2025 milestones, including producing a record 22.4 million pounds of PureFive resin with four consecutive quarters of sequential revenue growth, progress on facilities in Thailand and Antwerp, EU REACH and recycling certifications, and a €40 million EU grant for the Antwerp project.
Governance disclosures emphasize a largely independent board, formal clawback and anti‑hedging policies, committee structures, director stock ownership guidelines, and a mix of cash and RSU retainers. Detailed related‑party financing with Sylebra‑affiliated entities, Samlyn and others is outlined, covering a revolving credit facility, SOPA revenue bonds, convertible notes and preferred equity financings.
PureCycle Technologies is asking holders of its 5,893,827 outstanding PCT warrants to consent to amend the warrant agreement. The amendment would lower the stock price level needed to redeem warrants from $18.00 to $14.38 per share and, if approved, extend the warrant expiration from June 17, 2026 to March 17, 2027. Each warrant allows purchase of one share at $11.50. The company notes that at current prices the warrants are out of the money and could expire worthless, while the amendment and extension could increase the chances that holders realize value and enable PureCycle to receive up to about $67.8 million in gross proceeds if all warrants are exercised.
PureCycle Technologies, Inc. Chief Executive Officer Dustin Olson reported a tax-related share disposition. Olson surrendered 25,887 shares of common stock at a value of $5.79 per share to cover tax liability tied to the vesting of an equity award under the PureCycle Technologies, Inc. 2021 Equity and Incentive Compensation Plan. This was a tax-withholding disposition rather than an open-market sale. After this transaction, Olson directly holds 1,323,250 shares of PureCycle common stock.
PureCycle Technologies, Inc. General Counsel, CCO & Secretary Brad Kalter reported a tax-related share disposition. He surrendered 6,562 shares of Common Stock on March 22, 2026 to cover tax liability tied to the vesting of an equity grant under the 2021 Equity and Incentive Compensation Plan, rather than selling shares in the open market.
After this withholding, he continues to hold 183,327 Common Stock shares directly and 120,000 shares indirectly through the “Brad S. Kalter and Julie F. Kalter Revocable Trust,” indicating the transaction was a routine compensation and tax event rather than a change in investment stance.
PureCycle Technologies, Inc. filed a current report describing its participation in the 38th Annual ROTH Conference. CEO Dustin Olson will take part in a fireside chat on March 23, 2026 at 12:00 p.m. EDT, which will be streamed live online via webcast.
During the discussion, Olson plans to share information on PureCycle’s global expansion plans and provide additional updates on the company, which uses a patented dissolution recycling technology licensed from Procter & Gamble to purify polypropylene plastic waste into reusable PureFive™ resin.
PureCycle Technologies, Inc. is soliciting written consents from holders of its PCT Warrants to amend the Warrant Agreement to lower the redemption trigger price from $18.00 to $14.38 per share and, if approved, extend the warrants' expiration to the earlier of March 17, 2027 or the date fixed for redemption.
The Board unanimously approved the proposal, recommends that Registered Holders consent, and will effectuate the extension if the requisite majority of outstanding PCT Warrant consents are obtained. Each PCT Warrant is exercisable for one share of common stock at an exercise price of $11.50. Consents are solicited from holders of record as of March 17, 2026.